Prescription medicines
- Share of market value
- 65-70%
- Hospital procurement
- Primary channel
- Chronic disease therapies
- Growing
- Oncology and injectables
- High value
Exploring the future of healthcare in the Kingdom
A strategic initiative developing sustainable opportunities across pharmaceuticals, health products, distribution and healthcare investment.
USD 12-15 Billion
Current market
Mid 2020s
USD 18-24 Billion
Projected size by 2030
30-35%
Share of GCC pharmaceutical spending
5-8%
Growth through 2030
One of the largest healthcare markets in the region
The market is expanding on Vision 2030 reforms, private-sector participation, wider health insurance coverage, population growth and rising chronic and lifestyle-related disease. Historically dominated by originator brands, it is shifting toward generics and biosimilars, especially in public-sector procurement where cost efficiency and supply security drive decisions.
30-35%
Saudi share of GCC pharmaceutical spending
Market structure
Where the value sits
OTC and supplements
- Share of market value
- 30-35%
- Retail pharmacy chains
- Primary channel
- Preventive healthcare
- Growing
- Consumer wellness
- Growing
Food supplements
- Segment CAGR
- 7-10%
- Import dependence
- 80%+
- Sourced from
- EU, USA, Asia
- Regulator
- SFDA
Veterinary and animal health
- Estimated market size
- USD 350-650 Million
- Market growth
- 6-8%+
- Poultry self-sufficiency target
- 80%+
18-20%
Estimated adult diabetes prevalence
7-10%
Food supplements CAGR
80%+
Supplement import dependence
USD 350-650 Million
Veterinary market size
Six focus areas
Market intelligence
Opportunity identification grounded in real procurement and prescribing data rather than headline market size.
Strategic partnerships
Working with Saudi companies, distributors and investors already inside the system.
Regulatory awareness
SFDA compliance across ingredient limits, labelling and health claims.
Market entry
Distribution and commercialisation routes into hospital and retail channels.
Investment collaboration
Structuring participation alongside established healthcare operators.
Sustainable value
Long-term growth rather than opportunistic single-product entry.
Connecting opportunity with capability
- Healthcare transformation under Vision 2030
- Private-sector participation actively encouraged
- Localisation and supply security as national priorities
- Innovation and technology across the care pathway
- A more sustainable healthcare future